Print   Text Size   Email

Our Ventures

Regulus Therapeutics Inc. is a biopharmaceutical company formed (with Isis Pharmaceuticals) to discover, develop and commercialize miRNA therapeutics.

Visit regulusrx.com

Media Kit

Illustrations of RNAi development

Events

PAST EVENTS
ASCO 2010 Annual Meeting
Date: Jun 4, 2010 - Jun 8, 2010
Where: Chicago
About: Preliminary results from an ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement will be presented in the Developmental Therapeutics – Experimental Therapeutics poster session being held on Monday, June 7 from 8:00 a.m. to 12:00 p.m. in S Hall A2. For more information please see our news release.
Learn More: http://abstract.asco.org/AbstView_74_51118.html
RNAi Virtual Roundtable: Progress in Systemic Delivery
Date: Mar 4, 2010 - Mar 4, 2010
Where: webcast
About:
Learn More: http://tinyurl.com/alnyrdtablemar4
RNAi Roundtable: Delivery Progress (March 2010)
Keystone Symposia: Advances in Biopharmaceuticals
Date: Jan 8, 2010 - Jan 13, 2010
Where: Midway, Utah
About: Eight sessions covering both biotechnology discovery platforms supporting biopharmaceutical product research and development (4 sessions) and specific disease areas where biopharmaceuticals either have or are likely to have a major positive impact on clinical outcomes for patients (4 sessions).
Learn More: http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=1029
Keystone: Advances in BioPharmaceuticals (Jan 2010)
International Liposome Meeting
Date: Dec 12, 2009 - Dec 15, 2009
Where: London
About: Liposome advances: Recent progress in drug and vaccine delivery
Learn More: http://www.liposome.org/
EuroTIDES
Date: Dec 2, 2009 - Dec 3, 2009
Where: Lijnden Schiphol, Amsterdam, Netherlands
About:
Learn More: http://www.iir-events.com/IIR-conf/LifeSciences/EventView.aspx?EventID=2384
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics
Date: Nov 15, 2009 - Nov 19, 2008
Where: Hynes Convention Center
About: Alnylam presented new data demonstrating robust anti-tumor activity in orthotopic liver tumor models comprised of both HCC- and colorectal cancer-derived cell lines. ALN-VSP was also shown to act on disseminated tumors outside of the liver. Further, in addition to anti-proliferative effects, studies showed that ALN-VSP exerts a potent anti-angiogenic effect on tumors.
Learn More: http://www.aacr.org/home/scientists/meetings--workshops/molecular-targets-and-cancer-therapeutics.aspx
ALNY-AACR-VSPPoster-Nov17-2009.pdf
Alnylam R&D Day
Date: Nov 12, 2009 - Nov 12, 2009
Where: Loews Regency New York
About: Alnylam scientists and management will review and provide updates on Alnylam platform advancements, delivery strategies, and pipeline of novel RNAi therapeutics.
In addition, Alnylam will host two guest speakers:
    • Professor Allan R. Glanville, Director of Thoracic Medicine and Medical Director Lung Transplantation, St. Vincent’s Hospital, Sydney, will discuss respiratory syncytial virus (RSV) infection in the lung transplant patient population; and

      Professor Philip N. Hawkins, National Amyloidosis Centre, Division of Medicine, and University College London Medical School Royal Free Hospital, will discuss transthyretin (TTR)-mediated amyloidosis
    		•
    Learn More: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=148005&eventID=2521913
    AAPS Meeting (American Association Pharmaceutical Scientists)
    Date: Nov 8, 2009 - Nov 12, 2009
    Where: Los Angeles, CA
    About:
    Learn More: http://www.nxtbook.com/nxtbooks/aaps/prelimprogram_2009/#/0
    CHI: RNAi for Developing Targeted Therapeutics
    Date: Nov 3, 2009 - Nov 4, 2009
    Where: Boston, MA
    About:
    Learn More: http://www.discoveryontarget.com/tvd
    OTS Annual Meeting
    Date: Nov 3, 2009 - Nov 6, 2009
    Where: Japan
    About:
    Learn More: http://210.233.60.66/~bioorg/ots-ants/
    AASLD, The Liver Meeting
    Date: Oct 30, 2009 - Nov 3, 2009
    Where: Boston, MA
    About:
    Learn More: http://www.aasld.org/thelivermeeting/Pages/default.aspx
    Society for Neuroscience, “Neuroscience 2009”
    Date: Oct 17, 2009 - Oct 21, 2009
    Where: Chicago, IL
    About:
    Learn More: http://www.sfn.org/am2009/
    EMBO Conference
    Date: Oct 3, 2009 - Oct 8, 2009
    Where: Chania, Greece
    About: Endocytic Machineries in control of cell signaling and tissue morphogenesisn
    Learn More: http://cwp.embo.org/cfs09-08/
    Alnylam RNAi Roundtable: RNAi Lead Development
    Date: Sep 24, 2009 - Sep 24, 2009
    Where: Alnylam Pharmaceuticals
    About: Alnylam invites the financial community to join management and scientist to discuss RNAi Lead Development.
    Learn More:
    RLD RNAi Roundtable (Presentation)
    RLD RNAi Roundtable (MP3)
    World Congress on Huntington's Disease
    Date: Sep 14, 2009 - Sep 14, 2009
    Where: Vancouver, British Columbia, Canada
    About:
    Learn More: http://www.worldcongress-hd.net/html/2009/intro
    WCHD CNS Delivery Poster
    Alnylam RNAi Roundtable: ALN-RSV Program
    Date: Jul 30, 2009 - Jul 30, 2009
    Where: Alnylam Pharmaceuticals
    About: Archived event: Management discusson of the ALN-RSV Program

    Presentation materials and an audio recording of some or all of the Roundtable were made available after the event
    Learn More:
    RSV RNAi Roundtable (Presentation)
    RSV RNAi Roundtable (MP3)
    Alnylam RNAi Roundtable: Delivery
    Date: Jun 25, 2009 - Jun 25, 2009
    Where: Alnylam Pharmaceuticals
    About: Archived event: Alnylam management and scientists discussed the Delivery of RNAi
    Learn More:
    Delivery RNAi Roundtable (July 2009)
    Home     About Alnylam     Leadership in RNAi     Programs & Pipeline     Intellectual Property     Business Development     Events & Media Library     Investors
    Legal     Site Map   Copyright © 2008 Alnylam Pharmaceuticals, Inc. All Rights Reserved